News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search
here.
THE LATEST
Press Releases
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
August 18, 2025
·
13 min read
Press Releases
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH
August 18, 2025
·
4 min read
Press Releases
Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors
August 18, 2025
·
4 min read
Press Releases
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
August 18, 2025
·
15 min read
Press Releases
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
August 18, 2025
·
1 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
3 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
1 min read
Press Releases
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
3 min read
Press Releases
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
August 18, 2025
·
11 min read
Press Releases
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
August 18, 2025
·
3 min read
Press Releases
Gabby Thomas Partners with Babson Diagnostics’ BetterWay to Promote Accessible Healthcare
Olympic Gold Medalist and Public Health Advocate to Raise Awareness for Routine Blood Testing
August 15, 2025
·
1 min read
Press Releases
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
August 15, 2025
·
2 min read
Press Releases
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
August 15, 2025
·
11 min read
Press Releases
Novel Gene Therapy for ALS cleared for global trials in China and the U.S.
August 15, 2025
·
4 min read
Press Releases
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 15, 2025
·
14 min read
Press Releases
Santhera extends Highbridge convertible bond to 30th September 2025
August 15, 2025
·
2 min read
Press Releases
BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth.
August 15, 2025
·
6 min read
Press Releases
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
August 15, 2025
·
1 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
August 15, 2025
·
3 min read
Press Releases
Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux
August 15, 2025
·
3 min read
Press Releases
Encision Reports First Quarter Fiscal Year 2026 Results
August 15, 2025
·
5 min read
Press Releases
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 15, 2025
·
10 min read
Press Releases
HLS Therapeutics Announces Q2 2025 Financial Results
August 15, 2025
·
17 min read
Press Releases
Landmark Clinical Study Published in Spine Demonstrates Superiority of Tissue-Sparing Circumferential Cervical Fusion Over ACDF Alone in Multilevel Cervical Fusion Surgery
August 15, 2025
·
4 min read
Press Releases
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
August 18, 2025
·
8 min read
Press Releases
Nyxoah Reports Second Quarter 2025 Financial and Operating Results
August 18, 2025
·
11 min read
Press Releases
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - August 18, 2025
August 18, 2025
·
1 min read
Press Releases
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
August 18, 2025
·
6 min read
Press Releases
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
August 18, 2025
·
2 min read
Press Releases
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - August 18, 2025
August 18, 2025
·
2 min read
Press Releases
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 18, 2025
August 18, 2025
·
1 min read
Press Releases
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
August 18, 2025
·
12 min read
Press Releases
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
August 18, 2025
·
1 min read
Press Releases
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 18, 2025
August 18, 2025
·
1 min read
